A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)
Clinical trial NCT04449029 · COMPLETED
Trial details
- NCT number
- NCT04449029
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2022-03-18
- Enrollment
- 457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.